SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HuMAB companies

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: keokalani'nui who wrote (174)5/31/2001 12:09:08 PM
From: aknahow  Read Replies (1) of 1022
 
Thank you very much. Last night I looked at the Dyax web site and "learned" quite a bit about what they are doing.

I was unaware of Richard Lerner's thoughts about xomas technology or the importance of the alxn license. The CEO of XOMA seemed to be saying that those involved in the phage are would need to license the Xoma technology if they wanted to continue doing what they were doing. In addition, I think he said the majority have no problem coming to an agreement. The attitude seemed to be in words close to Castello's tell us what you want.

Final request, can you provide any link to any comment by Lerner on Xoma's technology?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext